English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Costs of licensing clinical trials
Share :
ECCO 15 - ESMO 34
20 - 24 Sep 2009
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
3 Nov 2009
Views:
10275
Rating:
Save
Rate video
Prof. John Smyth - Assistant Principal Cancer Research Development, University of Edinburgh
Discusses the issue of the cost of licensing trials with managing editor Professor Gordon McVie, at ECCO 15 - ESMO 34, Berlin, 2009.
Categories:
Drug development
Related Videos
Avelumab plus platinum-based chemotherapy may show some efficacy in patients...
Dr Giannis Mountzios - Henry Dunant Hospital Center, Athens, Greece
26 Apr 2024
Addition of atezolizumab to chemotherapy after surgery does not improve...
Dr Heather McArthur - UT Southwestern Medical Center, Dallas, USA
26 Apr 2024
EBCC 2024: Addressing inequalities across Europe in access to innovation for...
Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) and Dr...
25 Apr 2024
Comment: EBCC 2024 highlights
Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr...
25 Apr 2024
Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA
24 Apr 2024
Linvoseltamab induces deep and durable responses in patients with relapsed or...
Dr Sundar Jagannath - Icahn School of Medicine at Mount Sinai, New York, USA
24 Apr 2024
Autovaccination with the intratumoral viral mimic poly-ICLC makes a cold tumour...
Dr Sujit Nair - Icahn School of Medicine at Mount Sina, New York, USA
24 Apr 2024
Avelumab combined with regorafenib shows improved outcome in solid tumours with...
Prof Antoine Italiano - Institute Bergonié, Bordeaux, France
24 Apr 2024
Darolutamide, androgen-deprivation therapy and docetaxel demonstrate promising...
Prof Bertrand Tombal - Université Catholique de Louvain, Brussels, Belgium
16 Apr 2024
More from
e
cancer